Medicine
Meperidine 50 mg tablet
Meperidine 50 mg tablet is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25° C (68° to 77° F). Store meperidine hydrochloride tablets…
Key facts
- Active ingredient (INN)
- Meperidine
- Brand
- Sold under the generic name
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 30 tablets and 1 more
- Manufacturers
- Epic PharmaGenus Lifesciences
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25° C (68° to 77° F). Store meperidine hydrochloride tablets securely and dispose of properly.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CII
- ATC code
- N02AB02 Meperidine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 May 2011
- Identifiers
- RxCUI 861455, 861467DailyMed set ID fae5cc34-5917-4445-9516-25f97ffca8db, 792fefda-6cc4-4709-b902-fd9787fc310aNDC 42806-050, 64950-214Application ANDA040331, ANDA040893
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 42806-050-01 | Epic Pharma | 5 May 2011 |
| 30 tablet in 1 bottle | 42806-050-30 | Epic Pharma | 1 January 2020 |
| 100 tablet in 1 bottle, plastic | 64950-214-01 | Genus Lifesciences | 14 February 2024 |
| 30 tablet in 1 bottle, plastic | 64950-214-03 | Genus Lifesciences | 14 February 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 November 1942 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Meperidine
Clinical summary
Meperidine is an opioid agonist indicated for preoperative medication, support of anesthesia, and obstetrical analgesia, among other approved uses. It is available as injection, tablets and oral solution for intramuscular, intravenous and subcutaneous use. MedsAcross supplies Meperidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MeperidineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DEMEROL prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
Need Meperidine 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.